182 related articles for article (PubMed ID: 33468435)
1. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
Soni M
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
[TBL] [Abstract][Full Text] [Related]
3. The role of eosinophil as a diagnostic, differential, and prognostic marker for Covid-19 during pregnancy: Case-control study from tertiary center.
Atalay A; Sinaci S; Besimoglu B; Ozkavak O; Kaya E; Kara O; Sahin D
J Obstet Gynaecol Res; 2023 Aug; 49(8):2063-2072. PubMed ID: 37309016
[TBL] [Abstract][Full Text] [Related]
4. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
[TBL] [Abstract][Full Text] [Related]
5. Eosinopenia in COVID-19: What we missed so far?
Davido B; Partouche B; Jaffal K; de Truchis P; Herr M; Pepin M
J Microbiol Immunol Infect; 2021 Oct; 54(5):1006-1007. PubMed ID: 33648873
[No Abstract] [Full Text] [Related]
6. Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization.
Curtolo A; Oliva A; Volpicelli L; Ceccarelli G; D'Ettorre G; Borrazzo C; Mastroianni CM; Venditti M
Infez Med; 2020 Dec; 28(4):534-538. PubMed ID: 33257627
[TBL] [Abstract][Full Text] [Related]
7. A low level of CD16
Vasse M; Zuber B; Goubeau L; Ballester MC; Roumier M; Delcominette F; Habarou F; Jolly E; Ackermann F; Cerf C; Farfour E; Pascreau T;
Clin Chem Lab Med; 2021 Jun; 59(7):1315-1322. PubMed ID: 33606928
[TBL] [Abstract][Full Text] [Related]
8. The role of haematological parameters in patients with COVID-19 and influenza virus infection.
Kazancioglu S; Bastug A; Ozbay BO; Kemirtlek N; Bodur H
Epidemiol Infect; 2020 Nov; 148():e272. PubMed ID: 33148349
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of biological markers in the early prediction of corona virus disease-2019 severity.
Bennouar S; Bachir Cherif A; Kessira A; Hamel H; Boudahdir A; Bouamra A; Bennouar D; Abdi S
Scand J Clin Lab Invest; 2020 Dec; 80(8):611-618. PubMed ID: 32945705
[TBL] [Abstract][Full Text] [Related]
10. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
[TBL] [Abstract][Full Text] [Related]
11. Eosinopenia as a diagnostic marker of bloodstream infection in hospitalised paediatric and adult patients: a case-control study.
Wibrow BA; Ho KM; Flexman JP; Keil AD; Kohrs DL
Anaesth Intensive Care; 2011 Mar; 39(2):224-30. PubMed ID: 21485670
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil count (EC) as a diagnostic and prognostic marker for infection in the internal medicine department setting.
Karakonstantis S; Gryllou N; Papazoglou G; Lydakis C
Rom J Intern Med; 2019 Jun; 57(2):166-174. PubMed ID: 30517081
[TBL] [Abstract][Full Text] [Related]
13. Early Prediction of Severe COVID-19 in Patients by a Novel Immune-Related Predictive Model.
Sun C; Xue M; Yang M; Zhu L; Zhao Y; Lv X; Lin Y; Ma D; Shen X; Cheng Y; Xuan H; Jia X; Li T; Han L
mSphere; 2021 Oct; 6(5):e0075221. PubMed ID: 34643417
[TBL] [Abstract][Full Text] [Related]
14. The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.
Koenderman L; Siemers MJ; van Aalst C; Bongers SH; Spijkerman R; Bindels BJJ; Giustarini G; van Goor HMR; Kaasjager KAH; Vrisekoop N
Cells; 2021 May; 10(5):. PubMed ID: 34062964
[TBL] [Abstract][Full Text] [Related]
15. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.
Valverde-Monge M; Cañas JA; Barroso B; Betancor D; Ortega-Martin L; Gómez-López A; Rodríguez-Nieto MJ; Mahíllo-Fernández I; Sastre J; Del Pozo V
Front Immunol; 2021; 12():668074. PubMed ID: 34149705
[TBL] [Abstract][Full Text] [Related]
16. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab.
Pagella F; Lizzio R; Ugolini S; Spinozzi G; Maiorano E; Suppressa P; Sabbà C; Matti E
Orphanet J Rare Dis; 2020 Dec; 15(1):350. PubMed ID: 33339521
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.
Ramesh J; Reddy SLS; Rajesh M; Varghese J
Diabetes Metab Syndr; 2021; 15(3):739-745. PubMed ID: 33819728
[TBL] [Abstract][Full Text] [Related]
20. Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia.
Cazzaniga M; Fumagalli LAM; D'angelo L; Cerino M; Bonfanti G; Fumagalli RM; Schiavo G; Lorini C; Lainu E; Terragni S; Chiarelli M; Scarazzati C; Bonato C; Zago M
Int J Clin Pract; 2021 Jul; 75(7):e14047. PubMed ID: 33497517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
